Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-09 4:24 pm Sale | 2024-01-05 | 13G | Elevation Oncology, Inc. ELEV | Qiming U.S. Healthcare GP II LLC | 0 0.000% | -2,370,142 (Position Closed) | Filing History |
| 2024-01-09 09:07 am Purchase | 2023-12-31 | 13G | Elevation Oncology, Inc. ELEV | Empery Asset Management, LP | 4,000,000 6.700% | 4,000,000 (New Position) | Filing History |
| 2023-06-15 4:30 pm Purchase | 2023-06-13 | 13D | Elevation Oncology, Inc. ELEV | venBio Global Strategic Fund III, L.P. | 2,537,771 6.100% | 671,432 (+35.98%) | Filing History |
| 2023-06-09 4:15 pm Purchase | 2023-06-05 | 13G | Elevation Oncology, Inc. ELEV | ExodusPoint Capital Management, LP | 1,414,824 5.800% | 1,414,824 (New Position) | Filing History |
| 2023-06-08 4:30 pm Purchase | 2023-06-06 | 13G | Elevation Oncology, Inc. ELEV | Integrated Core Strategies (US) LLC | 1,397,382 5.700% | 1,397,382 (New Position) | Filing History |
| 2023-05-24 5:15 pm Purchase | 2023-05-17 | 13G | Elevation Oncology, Inc. ELEV | Point72 Asset Management, L.P. | 2,121,170 8.700% | 2,121,170 (New Position) | Filing History |
| 2023-02-24 4:00 pm Purchase | 2023-02-14 | 13G | Elevation Oncology, Inc. ELEV | TANG CAPITAL PARTNERS LP | 1,355,826 5.800% | 1,355,826 (New Position) | Filing History |
| 2023-02-14 3:15 pm Sale | 2022-12-31 | 13G | Elevation Oncology, Inc. ELEV | Cormorant Asset Management, LP | 1,952,032 8.380% | -31,136 (-1.57%) | Filing History |
| 2023-02-13 6:05 pm Purchase | 2022-12-31 | 13G | Elevation Oncology, Inc. ELEV | BIOTECHNOLOGY VALUE FUND L P | 2,312,200 9.900% | 700,502 (+43.46%) | Filing History |
| 2023-02-08 5:00 pm Purchase | 2022-12-31 | 13G | Elevation Oncology, Inc. ELEV | Aisling Capital IV LP | 2,876,561 12.340% | 10,413 (+0.36%) | Filing History |
| 2022-09-30 5:24 pm Purchase | 2022-07-27 | 13G | Elevation Oncology, Inc. ELEV | K2 HealthVentures Equity Trust LLC | 1,566,464 6.300% | 1,566,464 (New Position) | Filing History |
| 2022-09-26 4:21 pm Unchanged | 2021-06-29 | 13D | Elevation Oncology, Inc. ELEV | venBio Global Strategic Fund III, L.P. | 1,866,339 8.000% | 0 (Unchanged) | Filing History |
| 2022-07-11 10:28 am Sale | 2022-06-08 | 13G | Elevation Oncology, Inc. ELEV | DRIEHAUS CAPITAL MANAGEMENT LLC | 1,044,244 4.490% | -458,524 (-30.51%) | Filing History |
| 2022-06-10 09:02 am Sale | 2022-05-31 | 13G | Elevation Oncology, Inc. ELEV | DRIEHAUS CAPITAL MANAGEMENT LLC | 1,502,768 6.460% | -479,695 (-24.20%) | Filing History |
| 2022-05-27 5:26 pm Sale | 2022-05-25 | 13D | Elevation Oncology, Inc. ELEV | venBio Global Strategic Fund III, L.P. | 1,866,339 8.030% | -741,828 (-28.44%) | Filing History |
| 2022-02-14 4:21 pm Sale | 2021-12-31 | 13G | Elevation Oncology, Inc. ELEV | Boxer Capital LLC | 872,780 3.800% | -468,750 (-34.94%) | Filing History |
| 2022-02-14 1:46 pm Purchase | 2021-12-31 | 13G | Elevation Oncology, Inc. ELEV | BIOTECHNOLOGY VALUE FUND L P | 1,611,698 6.900% | 1,611,698 (New Position) | Filing History |
| 2022-02-14 12:16 pm Purchase | 2021-12-31 | 13G | Elevation Oncology, Inc. ELEV | Aisling Capital IV LP | 2,866,148 12.330% | 2,866,148 (New Position) | Filing History |
| 2022-02-14 09:19 am Purchase | 2021-12-31 | 13G | Elevation Oncology, Inc. ELEV | DRIEHAUS CAPITAL MANAGEMENT LLC | 1,982,463 8.540% | 1,982,463 (New Position) | Filing History |
| 2022-02-08 4:15 pm Purchase | 2021-06-29 | 13G | Elevation Oncology, Inc. ELEV | Qiming U.S. Healthcare GP II LLC | 2,370,142 10.200% | 2,370,142 (New Position) | Filing History |